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SUMMARY
Stunning and cumulative ischemic dysfunction occur in the left ventricle with coronary balloon occlusion.
Glucagon-like peptide (GLP)-1 protects the left ventricle against this dysfunction. This study used a conductance catheter method to evaluate whether the right ventricle (RV) developed similar dysfunction during right coronary artery balloon occlusion and whether GLP-1 was protective. In this study, the RV underwent significant stunning and cumulative ischemic dysfunction with right coronary artery balloon occlusion.
However, GLP-1 did not protect the RV against this dysfunction when infused after balloon occlusion. The present study investigated whether RV dysfunction occurs during serial coronary balloon occlusion, assessed by using the gold standard conductance catheter technique (25) (26) (27) (28) , and whether it is ameliorated by GLP-1. These data will confirm whether GLP-1 cardioprotection is confined to the left ventricle or whether it offers protection from RV ischemia. The study infusion was then immediately commenced. PV loop data were acquired after Giblett et al.
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30-min recovery and at the end of a further 1-min balloon occlusion (BO2). Once data collection was completed, PCI was performed at operator discre-
tion. An example of PV loops generated from the right ventricle during balloon occlusion is shown in Figure 2B .
Conductance catheter data were analyzed offline by Nottingham, United Kingdom). These syringes were chilled before collection, and the blood sample was immediately transferred to 2.5-ml ethylenediaminetetraacetic acid tubes, which had also been prepared, containing the protease inhibitor aprotinin (Trasylol, Nordic Group, Trondheim, Norway). These samples were kept in crushed ice until they were spun and stored at À20 C. Samples for insulin and free fatty acids were also collected.
Blood samples were collected into lithium-heparin tubes, which were also stored on crushed ice before centrifugation and storage at À20 C. All samples were spun within 1 h of collection. 
RESULTS
A total of 27 patients were recruited to the study.
Three patients were withdrawn from subsequent analysis for technical reasons. Patient demographic data are summarized in Table 1 . There were no statistically significant differences between the groups, although patients in the GLP-1 group trended toward having increased mean pulmonary artery pressure compared with the control group. Baseline hemodynamic data were broadly similar between groups.
However, there was a trend toward increased Tau Values are median (interquartile range), n (%), or mean AE SD.
CCS ¼ Canadian Cardiovascular Society functional classification of angina; dP/dtmax ¼ maximum rate of isovolumic contraction; dP/dtmin ¼ maximum rate of isovolumic relaxation; Ea ¼ effective arterial elastance; GLP-1 ¼ glucagon-like peptide 1; NYHA ¼ New York Heart Association; MI ¼ myocardial infarction; MAP ¼ mean arterial pressure; PA ¼ pulmonary artery; PCI ¼ percutaneous coronary intervention; RA ¼ right atrial; Tau ¼ time constant of diastolic relaxation.
EFFECT OF REPEATED CORONARY BALLOON
OCCLUSION ON RV FUNCTION. Occlusion of the RCA was associated with deterioration of systolic and diastolic function compared with baseline (BL1). At the end of the first balloon occlusion (BO1), stroke volume, ejection fraction, and dP/dt max were significantly reduced, with Tau and EDP increased ( Table 2) . either 30-min recovery or the second balloon occlusion ( Figure 3) .
BIOCHEMISTRY. Figure 4 shows that GLP-1 levels rose in the GLP-1-infused arm while remaining unchanged in the control arm. GLP-1 was metabolically active, causing a significant rise in insulin levels and a fall in plasma glucose levels. There was a small, but significant, drop in insulin levels in the control group. This reduction may represent the fasted nature of the cohort. However, there were no hypoglycemic episodes recorded during the study. Plasma free fatty acids rose in both groups as a result of the administration of unfractionated heparin required for the procedure (36), but there were no significant differences in free fatty acid levels between the groups. BO1 caused significant reduction in the (A) maximum rate of isovolumic contraction (dP/dt max ) and (B) stroke volume (SV) and (C) increases in end-diastolic pressure (EDP) and (D) the time constant of diastolic relaxation (Tau). *p < 0.05 versus BL1. Cumulative ischemic dysfunction measured according to dP/dt max after a second balloon occlusion was observed. **p < 0.05 versus BO1. There was no significant difference in any right ventricular index between GLP-1 and control saline. Mean AE SEM. Compared by using Student's t-test. GLP-1, n ¼ 11; control, n ¼ 13. Abbreviations as in Figure 1 . We confirmed that, like the left ventricle, when reactive hyperemia subsides, RV stunning is discernible and cumulative RV dysfunction can be observed.
GLP-1 abrogates LV stunning and cumulative ischemic dysfunction during both supply (coronary artery occlusion) and demand (dobutamine stress) ischemia, in a consistent manner (11, 13, 39) . The absence of a cardioprotective effect in the right Comparison of change in plasma levels of (A) GLP-1 (7 to 36) amide, (B) glucose, (C) insulin, and (D) free fatty acids (FFA). Mean AE SEM.
Compared by using Student's t-test. GLP-1, n ¼ 11; control, n ¼ 13. *p < 0.05 versus, BL1, †p < 0.05 versus control. Abbreviations as in 
